FTH Earnings Faeth Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Quarterly results
EPS
Reported EPS history
1–20 of 20
| Q2 2026 | 2026-06-30 | -53.50 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | -131.45 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -16.72 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -12.98 | 2025-11-14 | 10-Q |
| Q2 2026 | 2025-06-30 | -9.36 | 2026-08-04 | 10-Q |
| Q1 2026 | 2025-03-31 | -5.45 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -24.01 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -17.84 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -12.07 | 2025-08-05 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.32 | 2025-05-06 | 10-Q |
| FY 2024 | 2023-12-31 | -1.22 | 2025-03-28 | 10-K |
| Q3 2024 | 2023-09-30 | -0.92 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.64 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.33 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -1.58 | 2024-02-29 | 10-K |
| Q3 2023 | 2022-09-30 | -1.18 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.75 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.40 | 2023-05-09 | 10-Q |
| FY 2022 | 2021-12-31 | -1.33 | 2023-03-29 | 10-K |
| Q3 2022 | 2021-09-30 | -1.03 | 2022-11-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.